Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients

Infection Control and Hospital Epidemiology

Volumn 30, Issue 2, 2009, Pages 130-138

  Sang, Hoon Han ^a   Bum, Sik Chin ^a   Han, Sung Lee ^a   Su, Jin Jeong ^a   Hee, Kyung Choi ^a   Chang, Ki Kim ^a   Chang, Oh Kim ^a   Yong, Dongeun ^a   Jun, Yong Choi ^a   Young, Goo Song ^a   Lee, Kyungwon ^a   June, Myung Kim ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; METRONIDAZOLE; POLYPEPTIDE ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BLADDER CATHETERIZATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GENE TRANSFER; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; CARRIER STATE; CASE-CONTROL STUDIES; COHORT STUDIES; CULTURE MEDIA; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; KOREA; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 58849087112     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/593957     Document Type: Article

References (35)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
2. European Antimicrobial Resistance Surveillance System (EARSS) Management Team, members of the Advisory Board, and national representatives of EARSS. EARSS Annual Report 2006. Bilthoven, Netherlands: National Institute of Public Health and the Environment; 2007. Available at: http://www.rivm.nl/earss/ Images/EARSS%202006%20Def-tcm61-44176.pdf. Accessed August 30, 2008.
3. Kreman T, Hu J, Pottinger J, et al. Survey of long-term care facilities in Iowa for policies and practices regarding residents with methicillin- resistant Staphylococcus aureus or vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2005; 26:811-815.
4. Sader HS, Streit JM, Fritsche TR, et al. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin Microbiol Infect 2006; 12:844-852.
5. Streit JM, Jones RN, Sader HS, et al. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 2004; 24:111-118.
6. Hsueh PR, Chen WH, Teng LJ, et al. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 2005; 26:43-49.
7. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386.
8. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
9. DiazGranados CA, Zimmer SM, Klein M, et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41:327-333.
10. Appelbaum PC. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006; 12(Suppl 1):16-23.
11. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348:1342-1347.
12. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008; 46:668-674.
13. Francia MV, Clewell DB. Transfer origins in the conjugative Enterococcus faecalis plasmids pAD1 and pAM373: identification of the pAD1 nic site, a specific relaxase and a possible TraG-like protein. Mol Microbiol 2002; 45:375-395.
14. Noble WC, Rahman M, Karadec T, et al. Gentamicin resistance gene transfer from Enterococcus faecalis and E. faecium to Staphylococcus aureus, S. intermedius and S. hyicus. Vet Microbiol 1996; 52:143-152.
15. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72:195-198.
16. Weigel LM, Donlan RM, Shin DH, et al. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 2007; 51:231-238.
17. Warren DK, Nitin A, Hill C, et al. Occurrence of co-colonization or coinfection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2004; 25:99-104.
18. Furuno JP, Perencevich EN, Johnson JA, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization. Emerg Infect Dis 2005; 11:1539-1544.
19. Benson L, Sprague B, Campos J, et al. Epidemiology of infection and colonization with vancomycin-resistant enterococci and frequency of cocolonization with methicillin-resistant Staphylococcus aureus in children. Infect Control Hosp Epidemiol 2007; 28:880-882.
20. Domig KJ, Mayer HK, Kneifel W. Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp. 1. Media for isolation and enumeration. Int J Food Microbiol 2003; 88:147-164.
21. Domig KJ, Mayer HK, Kneifel W. Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp. 2. Pheno- and genotypic criteria. Int J Food Microbiol 2003; 88:165-188.
22. Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, et al., eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology; 1999:264-282.
23. Koneman EW, Allen SD, Janda WM, et al. The Gram-Positive Cocci: part 1: staphylococci and related genera. Philadelphia: Lippincott-Raven; 1997:539-576.
24. CLSI. Performance standards for antimicrobial disk susceptibility testing: 16th informational supplement. CLSI document.Wayne, PA: CLSI; 2007:M100-S17.
25. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
26. McGregor JC, Kim PW, Perencevich EN, et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005; 161:483-493.
27. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829.
28. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
29. Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 2006; 81:529-536.
30. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-751.
31. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. 2nd ed. Geneva: World Health Organization; 2006.
32. Christensen BB, Sternberg C, Andersen JB, et al. Establishment of new genetic traits in a microbial biofilm community. Appl Environ Microbiol 1998; 64:2247-2255.
33. Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 1999; 65:3710-3713.
34. Miyake M, Ohbayashi Y, Iwasaki A, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and use of a nasal mupirocin ointment in oral cancer inpatients. J Oral Maxillofac Surg 2007; 65:2159-2163.
35. Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004; 48:275-280.